Lupron Articles
53% jump in 1st-qtr profit for Abbott
15 April 2009
Repros' Proellex sees strong Ph II data
21 July 2008
Japan stock market week to July 7, 2008
14 July 2008
Japan stock market week to Aril 21, 2008
28 April 2008
Abbott reports 35% rise in earnings
28 April 2008
CellGenesys' $270M deal with Takeda
7 April 2008
Japan stock market week to March 24, 2008
31 March 2008
Japan stock market week to Jan 28, 2008
4 February 2008
Takeda set for $18.5B sales 2015, R&I says
28 January 2008
Japan stock market week to Oct 22, 2007
29 October 2007
Japan stock market week to April 23, 2007
30 April 2007
Abbott's 1st-qtr profit drops 19% to $697.5M
23 April 2007
Abbott suffers 4th-qtr $0.37 LPS on Kos buy
5 February 2007
Japan stock market week to Oct 23, 2006
30 October 2006
Three drug firms settle Illinois Lupron law suit
11 September 2006
Japan stock market week to July 24, 2006
26 July 2006
Takeda's 2005/6 income reaches 313.2B yen
22 May 2006
Japan stock market week to April 24, 2006
1 May 2006
Takeda 's income rises 14.4% in 1st 3 fiscal qtrs
20 February 2006
Japan stock market week to Jan 30, 2006
6 February 2006
Takeda's 1st-qtr stronger-than-expected due to volume growth
15 August 2005
Japan stock market week to July 18
25 July 2005
Norwood Immunology on track for BMT trial
11 July 2005
Strong 3rd-qtr for Takeda, as Actos and candesartan expand globally
21 February 2005
Japan stock market week to January 24
31 January 2005
Tokyo pharma stocks - week to October 18
25 October 2004
Tokyo pharma stocks - week to October 4
11 October 2004
Tokyo pharma stocks - week to April 19
26 April 2004
Abbott sees 13.9% rise in sales for 1st-qtr 2004
19 April 2004
Parke-Davis case
16 February 2004
Tokyo pharma stocks - week to Jan 19
26 January 2004
Abbott earnings up as core sales grow
20 October 2003
Abbott earnings up as core sales grow
20 October 2003
Atrix to miss targets on higher costs
29 September 2003
Tokyo pharma stocks - week to July 14
21 July 2003
Tokyo pharma stocks - week to Jan 20
27 January 2003
Praecis' Plenaxis effective in endometriosis
1 July 2002
FDA approves Atrix' prostate cancer depot
28 January 2002
MediGene files first application for Leuprogel
5 December 2001
Japan pharma stock market - week to October 15
17 October 2001
Stock Commentary - Tokyo
11 October 2001
Japan pharma stocks - week to October 8
9 October 2001
TAP to pay $875 million in Lupron case
4 October 2001
US doctors sentenced over Lupron scam
15 August 2001
Stock Commentary - Tokyo
19 July 2001
Japan pharma stocks - week to July 16
18 July 2001
Positive Ph III data for Praecis' abarelix
6 June 2001
TAP to be hit with $840 million fine?
31 May 2001
Japan pharma stock market week to May 21
23 May 2001
Stock Commentary - Tokyo
26 April 2001
Tokyo pharma stock market - week to April 23
25 April 2001
US pharma, doctors "kickbacks" warning
25 April 2001
Doctor, "Co X" accused over Medicare scam
22 February 2001
Stock Commentary - Tokyo
22 February 2001
Stock Commentary - Tokyo
25 January 2001
Stock Commentary - Tokyo
16 November 2000
Japan's Takeda posts net profits up 52% helped by sales abroad
7 November 2000
TAP under fire in Lupron pricing review
26 July 2000
Takeda benefits from strong US showing
24 May 2000
US doctors "billed insurers for free drugs"
14 April 2000
US doctors probed on Lupron "overbilling"
25 May 1999
TAP Holdings posts strong sales growth
8 April 1999
Increases In Sales And Earnings At Abbott
15 October 1997
TAP Holdings' Lupron Depot Approved In USA
23 July 1997
Synthelabo Licenses US Prostate Cancer Drug
9 June 1997
Lupron Receives Additional Indication
10 April 1995
Anandron Vote Overrules FDA Reviewer
6 March 1995
Takeda Advancing Despite Challenging Environment
5 September 1994
TAP SUB-LICENSES CEPHALON TECH
6 June 1994
EISAI'S SALES AHEAD IN FLAT JAPANESE SECTOR
6 June 1994
ZOLADEX LAUNCHED FOR ENDOMETRIOSIS
29 November 1993
ABBOTT'S HYTRIN GETS BPH APPROVAL IN USA
11 October 1993
TAKEDA ORDINARY PROFITS RISE
14 June 1993
NEW INDICATION FOR LUPRON DEPOT-PED
10 May 1993
ABBOTT ACHIEVES RECORD SALES
19 April 1993
WORLD ANTICANCER/ IMMUNOLOGY MARKET
8 February 1993
ARES SERONO - HOW TO PLAY THE STOCK
11 May 1992
Showing 1-93 of 93 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
